Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 8 of 8 entries
Sorted by: Best Match Show Resources per page
Molecular characterization of choline acetyltransferase from Drosophila melanogaster.

Neurochemistry international

Slemmon JR, Salvaterra PM, Roberts E.
PMID: 20488078
Neurochem Int. 1984;6(4):519-25. doi: 10.1016/0197-0186(84)90124-4.

Purified acetyl-CoA: choline O-acetyltransferase (EC 2.3.1.6) from Drosophila melanogaster has been shown to contain two major polypeptides of 67 and 54 K Daltons. However, all enzyme activity is found in a single molecular weight form of approx 67 K...

Regulation of putative muscarinic cholinergic receptor subtypes in rat brain.

Neurochemistry international

Norman AB, Battaglia G, Creese I.
PMID: 20493134
Neurochem Int. 1986;9(2):337-47. doi: 10.1016/0197-0186(86)90071-9.

Transection of the fimbria/fornix, producing a 75% reduction in the activity of the cholinergic marker choline-o-acetyltransferase (CAT EC. 2.3.1.6) in rat hippocampus, did not change the binding characteristics of the non-subtype selective, muscarinic cholinergic receptor antagonist ligand [(3)H](?)quinuclidinyl benzilate...

Choline acetyltransferase from a temperature-sensitive mutant of caenorhabditis elegans.

Neurochemistry international

Sassa T, Hosono R, Kuno S.
PMID: 20501178
Neurochem Int. 1987;11(3):323-9. doi: 10.1016/0197-0186(87)90053-2.

A temperature dependent paralytic mutant of C. elegans was isolated and mapped to be an allele of the cha-1 gene that has been shown to be the structural gene for acetyl-CoA: choline-O-acetyltransferase (EC 2.3.1.6; ChAT) (Hosono et al., J....

Immunocytochemical staining of central neurones in Periplaneta americana using monoclonal antibodies to choline acetyltransferase.

Tissue & cell

Sattelle DB, Ho YW, Crawford GD, Salvaterra PM, Mason WT.
PMID: 18620156
Tissue Cell. 1986;18(1):51-61. doi: 10.1016/0040-8166(86)90006-6.

Immunocytochemical mapping of cholinergic neurones in the CNS of the cockroach Periplaneta americana has been attempted using monoclonal antibodies to choline acetyltransferase (ChAT, acetyl-CoA: choline O-acetyltransferase, EC 2.3.1.6). Monoclonal antibodies 11 255 and 1E6 raised against rat brain ChAT...

[(3)H]ketanserin binding increases in monkey cortex following basal forebrain lesions with ibotenic acid.

Neurochemistry international

Wenk GL, Engisch KL, McCall LD, Mitchell SJ, Aigner TG, Struble RL, Price DL, Olton DS.
PMID: 20493162
Neurochem Int. 1986;9(4):557-62. doi: 10.1016/0197-0186(86)90150-6.

The present study investigated the effects of damage to the basal forebrain cholinergic system upon [(3)H]ketanserin binding in the neocortex and hippocampus of monkeys. [(3)H]Ketanserin specifically binds to serotonin type-2 receptor sites. Lesions were placed in the medial septal...

Botulinum neurotoxin inhibits the release of newly synthesized acetylcholine from torpedo electric organ synaptosomes.

Neurochemistry international

Marsal J, Solsona C, Rabasseda X, Blasi J.
PMID: 20501249
Neurochem Int. 1988;12(4):439-45. doi: 10.1016/0197-0186(88)90026-5.

In previous reports, we have shown that botulinum neurotoxin inhibits acetylcholine release from Torpedo marmorata electric organ and from its synaptosomal fraction. Here, we have focussed our attention on the study of the effect of botulinum neurotoxin on the...

Immunological, isoelectric, hydrophobic and molecular weight differences between soluble and ionically membrane-bound fractions of choline-o-acetyltransferase prepared from mouse and rat brain.

Neurochemistry international

Badamchian M, Morrow KJ, Carroll PT.
PMID: 20493141
Neurochem Int. 1986;9(3):409-21. doi: 10.1016/0197-0186(86)90083-5.

Choline-O-acetyltransferase (EC 2.3.1.6; ChAT) was prepared from synaptosomal fractions (P(2)) of mouse and rat brain in the presence of proteolytic inhibitors by the method of Gray and Whittaker (1962) as modified by (Salehmoghaddam and Collier, 1976). The P(2) fraction...

Integrating precision medicine in the study and clinical treatment of a severely mentally ill person.

PeerJ

O'Rawe JA, Fang H, Rynearson S, Robison R, Kiruluta ES, Higgins G, Eilbeck K, Reese MG, Lyon GJ.
PMID: 24109560
PeerJ. 2013 Oct 03;1:e177. doi: 10.7717/peerj.177. eCollection 2013.

Background. In recent years, there has been an explosion in the number of technical and medical diagnostic platforms being developed. This has greatly improved our ability to more accurately, and more comprehensively, explore and characterize human biological systems on...

Showing 1 to 8 of 8 entries